Esketamine (Spravato™) is FDA-approved for treatment-resistant depression.  It is chemically related to ketamine, which is also used for depression.  Given intranasally, esketamine must be administered and monitored in an approved clinic, and will require 2 hours of observation in the clinic following each administration.

The course of treatment is twice weekly for 4 weeks, then weekly to every other week indefinitely.

An evaluation in the office is required before approval for ketamine or esketamine treatment, even if you have received ketamine treatments somewhere else in the past.  Lott Behavioral Health is approved for giving esketamine (Spravato™) treatments, and we are now listed in the treatment locator.

We are in Lisle, IL off I-88 with convenient access from Naperville, Oak Brook, Elmhurst, Hinsdale, Western Springs, Downers Grove, Lombard and other surrounding areas.  Please call 630-730-5506 to schedule an evaluation.

For more information, also see the official Spravato™ website , our esketamine FAQ page, and our ketamine FAQ page.